Skip to content

Public FDA record

Z-0856-2022: Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm

Recall record Z-0856-2022 for SA3, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0856-2022
Company in FDA record
SA3, LLC
FDA record creation date
Apr 4, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to failure of microbial testing for total aerobic microbial count (TAMC).

Source facts

Action
On 02/21/2022, the firm emailed an Urgent Recall Notification to customers informing them that the recall has been initiated due to the affected lot's microbial testing results for total aerobic microbial count (TAMC exceeded specifications prior to expiry of the gel. Customer are instructed to: 1. Immediately examine your inventory and quarantine product subject to this recall. 2. Immediately discontinue use and distribution of the identified lot number. 3. To request a prepaid shipping label, complete and return the enclosed Customer Market Withdrawal Return Response Form via email at info@alexso.com or via fax at 888-502-1669. 4. If customer have further distributed this product to other wholesalers or pharmacies, please identify and notify them at once of this product market recall. The Recall notification and return response form should be include when notifying these customers. 5. Return the affected product to: Alexso, Inc. c/o Recall 2317 Cotner Ave Los Angeles, CA 90064 For any questions, contact the Recalling Firm at (888)-495-6078, Monday through Friday 9:00 AM to 5:00 PM PST or email at info@alexso.com. On 03/07/2022, the firm emailed an updated "URGENT: Medical Device Market Removal" letter which informs customers of the potential risks/harms/hazards associated with use of the affected products and added that it is recommended that physicians monitor their patents for potential adverse reactions and events as a result of use of the affected product.
Initiated
2022-02-21
Root cause
Under Investigation by firm
Terminated
2024-05-15
Distribution
U.S. Nationwide distribution in the states of CA, FL and GA.
Recall number
Z-0856-2022
Recall status
Terminated
CDRH record ID
192221
FDA record created
2022-04-04
Recall event number
89687

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗